Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein A-I and apolipoprotein A-I milano

Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein A-I and apolipoprotein A-I milano

US Patent 8926958 · Granted Jan 6, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adeno-associated virus compositions for restoring HBB gene function and methods 2025
Adeno-associated virus compositions for restoring HBB gene function and methods 2025
System, device and method for production of bioproduct including high density ce2024
Adeno-associated virus vector variants for high efficiency genome editing and me2024
Adeno-associated virus vector variants for high efficiency genome editing and me2024
Adeno-associated virus compositions for restoring F8 gene function and methods o2024
Recombinant adeno-associated vectors for targeted treatment2023
Recombinant adeno-associated vectors for targeted treatment2023
Adeno-associated virus vector variants for high efficiency genome editing and me2022
Adeno-associated virus vector variants for high efficiency genome editing and me2022
Adeno-associated virus compositions for restoring F8 gene function and methods o2022
Recombinant adeno-associated vectors for targeted treatment2020